Founded:
April 1965
Factory:
Toyama City, Japan
Marketing Branches:
7 branches across Japan
Fiscal Year:
September
More Information:
• R&D (Research Div.)
• Toyama Factory
• Business Development Dep.
• Management Affairs Dep.
• Sales & Marketing Dep.
• R&D (Development Div.)
Fuji Pharma is a renowned Japanese pharmaceutical firm. The company invests in the development, manufacturing and marketing of pharmaceutical products, such as injection agents, drugs for internal and external use, and diagnostic products.
People seeking good health and are involved in medical services and pharmaceuticals
Medical care for women, in vitro diagnostics, acute medical care products and curative medicine (injection agents), and information regarding pharmaceuticals and health
Research and development, manufacturing, and marketing in selected disease domains. Passionate about the quality of products, people, and management. Hard-working employees and partners.
Chairman and Representative Director
President & CEO
![]() |
In all its endeavors since its foundation in 1959, Fuji Pharma has placed the highest priority on contributing to the healthy lives of people around the world under its Management Philosophy, with a high sense of ethics and passion. The philosophy consists of "We help people lead healthy lives by offering excellent pharmaceuticals" and "Our corporate growth is proportional to our personal growth." Fuji Pharma believes that its philosophy contributes to valuing pride in our involvement in people's lives, joy and happiness in serving people, and gratitude for people. By creating new value together with patients and medical professionals, Fuji Pharma has increased the value of its existence and grown to earn the confidence of its many stakeholders.
It is Fuji Pharma's strong intention that its continued contribution to healthy living will lead to personal growth in each and every one of its employees and generate high-quality work by them, that the accumulation of that high-quality work will lead to corporate growth, and that such corporate growth will be passed on to the healthy lives of all. In this way, we will continue to contribute to the happiness of people around the world.
By further evolving the strengths that we have cultivated to date, primarily in women's healthcare, we will continue to focus our efforts on the development, manufacture, and sale of high value-added products (new drugs, biosimilars, etc.) to respond swiftly and flexibly to increasingly diverse medical needs.
With our intentions to continue contributing to the healthy lives of people around the world, together with patients and medical professionals, we will constantly strive to create the kind of new value for the future that only Fuji Pharma can, in our aim to become the "Fuji Pharma Group" that can continue to contribute to the happiness of people around the world.
Takayuki Iwai
Shuhei Morita |